Literature DB >> 20656636

High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis.

Christophe Meune1, Emmanuel Touzé, Ludovic Trinquart, Yannick Allanore.   

Abstract

BACKGROUND: While there are convergent data suggesting that overall cardiovascular mortality is increased in patients with rheumatoid arthritis, the relative contributions of myocardial infarction and stroke remain unclear. AIMS: We sought to clarify this issue by conducting a meta-analysis of cohort studies on myocardial infarction and stroke in patients with rheumatoid arthritis.
METHODS: A MEDLINE search from January 1960 to September 2009 and abstracts from international conferences from 2007 to 2009 were searched for relevant literature. All cohort studies reporting on standardized mortality ratio or incidence rate ratio of myocardial or stroke associated with rheumatoid arthritis, with available crude numbers, were included. STATA meta-analysis software was used to calculate pooled risk estimates.
RESULTS: Seventeen papers fulfilled the inclusion criteria, corresponding to a total of 124,894 patients. Ten studies reported on standardized mortality ratio for fatal myocardial infarction, which ranged from 0.99 to 3.82. The overall pooled estimate was 1.77 (95% confidence interval [CI] 1.65-1.89). Incidence rate ratio for myocardial infarction was reported in five studies; the pooled estimate was 2.10 (95% CI 1.52-2.89). Nine studies reported on fatal stroke, with standardized mortality ratio ranging from 1.08 to 2.00; the pooled estimate was 1.46 (95% CI 1.31-1.63). The pooled incidence rate ratio for stroke (three studies) was 1.91 (95% CI 1.73-2.12).
CONCLUSION: Our results show that risks of myocardial infarction and stroke are increased in patients with rheumatoid arthritis. In addition, both account for the observed increased mortality in individuals with rheumatoid arthritis. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20656636     DOI: 10.1016/j.acvd.2010.03.007

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  58 in total

1.  [The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality].

Authors:  O Sander
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

2.  Assessment of cognitive function in female rheumatoid arthritis patients: associations with cerebrovascular pathology, depression and anxiety.

Authors:  Csaba Oláh; Zsófia Kardos; Mónika Andrejkovics; Enikő Szarka; Katalin Hodosi; Andrea Domján; Mariann Sepsi; Attila Sas; László Kostyál; Katalin Fazekas; Ágnes Flórián; Katalin Lukács; Ágnes Miksi; Zsuzsanna Baráth; György Kerekes; Márta Péntek; Attila Valikovics; László Tamási; Dániel Bereczki; Zoltán Szekanecz
Journal:  Rheumatol Int       Date:  2019-09-25       Impact factor: 2.631

3.  Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.

Authors:  Suad Hannawi; Issa AlSalmi; Ingrid Moller; Esperanza Naredo
Journal:  Clin Rheumatol       Date:  2017-06-30       Impact factor: 2.980

4.  Body composition in patients with rheumatoid arthritis is not different than healthy subjects.

Authors:  Servet Akar; İsmail Sarı; Abdurrahman Çömlekci; Merih Birlik; Fatoş Önen; Yiğit Göktay; Dinc Özaksoy; Nurullah Akkoç
Journal:  Eur J Rheumatol       Date:  2014-09-01

5.  Perceptions of physical activity engagement among adults with rheumatoid arthritis and rheumatologists.

Authors:  Maura D Iversen; Lauren Scanlon; Michelle Frits; Nancy A Shadick; Nancy Sharby
Journal:  Int J Clin Rheumtol       Date:  2015

6.  Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.

Authors:  Joseph J Keller; Jung-Lung Hsu; Shiue-Ming Lin; Chia-Chi Chou; Li-Hsuan Wang; Jui Wang; Chyi-Huey Bai; Hung-Yi Chiou
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

7.  Comparison of Subjective and Objective Measures of Sedentary Behavior Using the Yale Physical Activity Survey and Accelerometry in Patients With Rheumatoid Arthritis.

Authors:  Abigail L Gilbert; Jungwha Lee; Madeleine Ma; Pamela A Semanik; Loretta DiPietro; Dorothy D Dunlop; Rowland W Chang
Journal:  J Phys Act Health       Date:  2015-09-17

8.  Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis.

Authors:  Dragana Dragoljevic; Michael J Kraakman; Prabhakara R Nagareddy; Devi Ngo; Waled Shihata; Helene L Kammoun; Alexandra Whillas; Man Kit Sam Lee; Annas Al-Sharea; Gerard Pernes; Michelle C Flynn; Graeme I Lancaster; Mark A Febbraio; Jaye Chin-Dusting; Beatriz Y Hanaoka; Ian P Wicks; Andrew J Murphy
Journal:  Eur Heart J       Date:  2018-06-14       Impact factor: 29.983

9.  Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Simin Liu; Christine G Parks; Nicole C Wright; Larry W Moreland
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

Review 10.  Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis.

Authors:  Antongiulio Scarno; Fabio Massimo Perrotta; Francesca Cardini; Alessia Carboni; Gianmarco Annibali; Ennio Lubrano; Antonio Spadaro
Journal:  World J Orthop       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.